$2.97B Market Cap.
AMED Market Cap. (MRY)
AMED Shares Outstanding (MRY)
AMED Assets (MRY)
Total Assets
$2.14B
Total Liabilities
$958.75M
Total Investments
$0
AMED Income (MRY)
Revenue
$2.35B
Net Income
$43.23M
Operating Expense
$923.14M
AMED Cash Flow (MRY)
CF Operations
$221.66M
CF Investing
-$8.36M
CF Financing
-$48.92M
AMED Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
AMED Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $2,138,714,000 (3.81%) | $2,060,170,000 (4.25%) | $1,976,245,000 (6.42%) | $1,856,968,000 (18.49%) |
Assets Current | $632,083,000 (27.20%) | $496,935,000 (27.76%) | $388,961,000 (9.05%) | $356,684,000 (-1.46%) |
Assets Non-Current | $1,506,631,000 (-3.62%) | $1,563,235,000 (-1.52%) | $1,587,284,000 (5.80%) | $1,500,284,000 (24.48%) |
Goodwill & Intangible Assets | $1,295,043,000 (-3.88%) | $1,347,354,000 (-2.97%) | $1,388,566,000 (6.22%) | $1,307,280,000 (29.84%) |
Shareholders Equity | $1,134,541,000 (6.38%) | $1,066,514,000 (1.42%) | $1,051,573,000 (12.91%) | $931,351,000 (15.09%) |
Property Plant & Equipment Net | $123,608,000 (-5.49%) | $130,784,000 (10.01%) | $118,882,000 (-0.68%) | $119,692,000 (2.16%) |
Cash & Equivalents | $303,242,000 (118.37%) | $138,863,000 (156.52%) | $54,133,000 (18.27%) | $45,769,000 (-45.09%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $296,075,000 (-5.52%) | $313,373,000 (5.59%) | $296,785,000 (7.94%) | $274,961,000 (7.77%) |
Trade & Non-Trade Payables | $39,956,000 (41.50%) | $28,237,000 (-35.44%) | $43,735,000 (14.44%) | $38,217,000 (-10.44%) |
Accumulated Retained Earnings (Deficit) | $791,156,000 (5.78%) | $747,925,000 (-1.29%) | $757,672,000 (18.56%) | $639,063,000 (48.62%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $289,000 (-99.40%) |
Tax Liabilities | $48,051,000 (18.25%) | $40,635,000 (99.08%) | $20,411,000 (0%) | $0 (0%) |
Total Debt | $459,301,000 (-5.73%) | $487,213,000 (-9.43%) | $537,941,000 (-1.41%) | $545,612,000 (77.70%) |
Debt Current | $63,877,000 (2.04%) | $62,600,000 (27.71%) | $49,017,000 (10.83%) | $44,228,000 (9.09%) |
Debt Non-Current | $395,424,000 (-6.87%) | $424,613,000 (-13.15%) | $488,924,000 (-2.49%) | $501,384,000 (88.14%) |
Total Liabilities | $958,749,000 (1.95%) | $940,387,000 (8.13%) | $869,672,000 (-1.25%) | $880,645,000 (16.42%) |
Liabilities Current | $514,392,000 (8.59%) | $473,721,000 (33.24%) | $355,529,000 (-5.01%) | $374,282,000 (-17.98%) |
Liabilities Non-Current | $444,357,000 (-4.78%) | $466,666,000 (-9.23%) | $514,143,000 (1.54%) | $506,363,000 (68.72%) |
AMED Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $2,348,324,000 (5.01%) | $2,236,382,000 (0.59%) | $2,223,199,000 (0.41%) | $2,214,112,000 (6.88%) |
Cost of Revenue | $1,330,647,000 (6.84%) | $1,245,509,000 (-1.18%) | $1,260,425,000 (2.19%) | $1,233,356,000 (4.05%) |
Selling General & Administrative Expense | $529,748,000 (2.65%) | $516,049,000 (1.43%) | $508,791,000 (7.18%) | $474,718,000 (5.62%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $923,139,000 (10.62%) | $834,479,000 (6.71%) | $782,002,000 (7.29%) | $728,841,000 (9.29%) |
Interest Expense | $30,764,000 (-1.63%) | $31,274,000 (40.70%) | $22,228,000 (133.36%) | $9,525,000 (-13.71%) |
Income Tax Expense | $48,054,000 (-4.95%) | $50,559,000 (18.84%) | $42,545,000 (-39.28%) | $70,065,000 (173.32%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $38,162,000 (448.96%) | -$10,936,000 (-109.29%) | $117,699,000 (-44.00%) | $210,166,000 (13.49%) |
Net Income to Non-Controlling Interests | -$5,069,000 (-326.32%) | -$1,189,000 (-30.66%) | -$910,000 (-183.18%) | $1,094,000 (-30.58%) |
Net Income | $43,231,000 (543.53%) | -$9,747,000 (-108.22%) | $118,609,000 (-43.27%) | $209,072,000 (13.87%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $43,231,000 (543.53%) | -$9,747,000 (-108.22%) | $118,609,000 (-43.27%) | $209,072,000 (13.87%) |
Weighted Average Shares | $32,718,000 (0.37%) | $32,599,000 (0.25%) | $32,517,000 (-0.38%) | $32,642,000 (0.25%) |
Weighted Average Shares Diluted | $33,051,000 (1.39%) | $32,599,000 (-0.17%) | $32,653,000 (-0.97%) | $32,972,000 (-0.89%) |
Earning Before Interest & Taxes (EBIT) | $122,049,000 (69.31%) | $72,086,000 (-60.69%) | $183,382,000 (-36.47%) | $288,662,000 (31.04%) |
Gross Profit | $1,017,677,000 (2.71%) | $990,873,000 (2.92%) | $962,774,000 (-1.83%) | $980,756,000 (10.68%) |
Operating Income | $94,538,000 (-39.55%) | $156,394,000 (-13.49%) | $180,772,000 (-28.24%) | $251,915,000 (14.89%) |
AMED Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$8,364,000 (-123.85%) | $35,064,000 (137.11%) | -$94,486,000 (66.45%) | -$281,607,000 (1.92%) |
Net Cash Flow from Financing | -$48,922,000 (44.10%) | -$87,522,000 (-187.59%) | -$30,433,000 (-155.21%) | $55,126,000 (468.07%) |
Net Cash Flow from Operations | $221,665,000 (61.58%) | $137,188,000 (2.93%) | $133,283,000 (-29.44%) | $188,893,000 (-34.63%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $164,379,000 (94.00%) | $84,730,000 (913.03%) | $8,364,000 (122.25%) | -$37,588,000 (-186.21%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $47,437,000 (165.93%) | -$71,952,000 (73.35%) | -$269,965,000 (9.70%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$1,046,000 (-797.33%) | $150,000 (100.96%) | -$15,637,000 (-200.71%) | -$5,200,000 (-130.59%) |
Capital Expenditure | -$6,550,000 (-19.44%) | -$5,484,000 (10.08%) | -$6,099,000 (0.96%) | -$6,158,000 (-17.25%) |
Issuance (Repayment) of Debt Securities | -$37,357,000 (50.85%) | -$76,013,000 (-471.70%) | -$13,296,000 (-105.85%) | $227,377,000 (877.38%) |
Issuance (Purchase) of Equity Shares | $309,000 (-88.56%) | $2,702,000 (124.13%) | -$11,199,000 (88.07%) | -$93,856,000 (-1049.29%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $30,639,000 (5.56%) | $29,024,000 (75.27%) | $16,560,000 (-30.45%) | $23,809,000 (-10.93%) |
Depreciation Amortization & Accretion | $60,461,000 (4.53%) | $57,843,000 (-18.49%) | $70,964,000 (-0.42%) | $71,265,000 (4.89%) |
AMED Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 43.30% (-2.26%) | 44.30% (2.31%) | 43.30% (-2.26%) | 44.30% (3.50%) |
Profit Margin | 1.80% (550.00%) | -0.40% (-107.55%) | 5.30% (-43.62%) | 9.40% (5.62%) |
EBITDA Margin | 7.80% (34.48%) | 5.80% (-49.12%) | 11.40% (-30.06%) | 16.30% (17.27%) |
Return on Average Equity (ROAE) | 3.80% (522.22%) | -0.90% (-107.63%) | 11.80% (-50.63%) | 23.90% (-3.63%) |
Return on Average Assets (ROAA) | 2.00% (500.00%) | -0.50% (-108.33%) | 6.00% (-50.00%) | 12.00% (2.56%) |
Return on Sales (ROS) | 5.20% (62.50%) | 3.20% (-60.98%) | 8.20% (-36.92%) | 13.00% (22.64%) |
Return on Invested Capital (ROIC) | 21.70% (80.83%) | 12.00% (-53.31%) | 25.70% (-55.92%) | 58.30% (25.38%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 68.78 (121.71%) | -316.87 (-1484.42%) | 22.89 (-9.37%) | 25.25 (-51.44%) |
Price to Sales Ratio (P/S) | 1.26 (-8.73%) | 1.39 (13.42%) | 1.22 (-48.81%) | 2.39 (-48.22%) |
Price to Book Ratio (P/B) | 2.62 (-9.90%) | 2.91 (12.71%) | 2.58 (-54.46%) | 5.67 (-52.35%) |
Debt to Equity Ratio (D/E) | 0.84 (-4.20%) | 0.88 (6.65%) | 0.83 (-12.58%) | 0.95 (1.18%) |
Earnings Per Share (EPS) | 1.32 (540.00%) | -0.3 (-108.22%) | 3.65 (-43.06%) | 6.41 (13.65%) |
Sales Per Share (SPS) | 71.78 (4.62%) | 68.6 (0.34%) | 68.37 (0.80%) | 67.83 (6.61%) |
Free Cash Flow Per Share (FCFPS) | 6.58 (62.75%) | 4.04 (3.30%) | 3.91 (-30.14%) | 5.6 (-35.75%) |
Book Value Per Share (BVPS) | 34.68 (5.99%) | 32.72 (1.17%) | 32.34 (13.34%) | 28.53 (14.80%) |
Tangible Assets Book Value Per Share (TABVPS) | 25.79 (17.93%) | 21.87 (20.99%) | 18.07 (7.32%) | 16.84 (-2.15%) |
Enterprise Value Over EBIT (EV/EBIT) | 26 (-46.94%) | 49 (172.22%) | 18 (-10.00%) | 20 (-55.56%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 17.51 (-34.97%) | 26.93 (111.04%) | 12.76 (-19.40%) | 15.83 (-53.98%) |
Asset Turnover | 1.11 (-0.81%) | 1.12 (-1.24%) | 1.13 (-11.09%) | 1.27 (-4.08%) |
Current Ratio | 1.23 (17.16%) | 1.05 (-4.11%) | 1.09 (14.80%) | 0.95 (20.18%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $215,115,000 (63.33%) | $131,704,000 (3.55%) | $127,184,000 (-30.40%) | $182,735,000 (-35.59%) |
Enterprise Value (EV) | $3,195,695,183 (-8.65%) | $3,498,315,966 (7.81%) | $3,244,881,678 (-43.04%) | $5,696,754,559 (-42.53%) |
Earnings Before Tax (EBT) | $91,285,000 (123.67%) | $40,812,000 (-74.68%) | $161,154,000 (-42.27%) | $279,137,000 (33.40%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $182,510,000 (40.47%) | $129,929,000 (-48.92%) | $254,346,000 (-29.33%) | $359,927,000 (24.88%) |
Invested Capital | $485,338,000 (-17.38%) | $587,445,000 (-17.95%) | $715,958,000 (6.03%) | $675,249,000 (106.07%) |
Working Capital | $117,691,000 (406.98%) | $23,214,000 (-30.56%) | $33,432,000 (289.98%) | -$17,598,000 (81.35%) |
Tangible Asset Value | $843,671,000 (18.36%) | $712,816,000 (21.29%) | $587,679,000 (6.91%) | $549,688,000 (-1.90%) |
Market Capitalization | $2,973,475,183 (-4.15%) | $3,102,125,966 (14.28%) | $2,714,380,678 (-48.57%) | $5,277,680,559 (-45.16%) |
Average Equity | $1,123,923,000 (7.24%) | $1,048,080,250 (4.29%) | $1,004,929,000 (14.88%) | $874,760,000 (17.99%) |
Average Assets | $2,121,266,750 (5.84%) | $2,004,237,000 (1.90%) | $1,966,937,500 (12.92%) | $1,741,846,250 (11.38%) |
Invested Capital Average | $561,276,500 (-6.70%) | $601,614,500 (-15.65%) | $713,236,250 (44.05%) | $495,129,500 (4.48%) |
Shares | 32,751,131 (0.36%) | 32,633,347 (0.44%) | 32,491,988 (-0.34%) | 32,602,425 (-0.63%) |
